Oxford, Oxfordshire, UNITED KINGDOM
2021
Biotechnology
2
$15.35M
Every filing
| Filed | Type | Amount sold | Total offering | Records |
|---|---|---|---|---|
| 2026-09-02 | New offering first sale 2026-08-17 | $13.52M | $15M | details · SEC filing |
| 2023-02-21 | New offering first sale 2023-02-06 | $1.83M | $3M | SEC filing |
Want the whole picture on Sensible Biotechnologies, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Sensible Biotechnologies, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Sensible Biotechnologies, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
3 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.
Every figure here is read from Sensible Biotechnologies, Inc.'s own filings with the SEC.
Founders and team named in these filings
| Name | Role stated in the filing | Named in |
|---|---|---|
| Marian Kupculak | Executive Officer, Director | 2026-09-02, 2023-02-21 |
| Miroslav Gasparek | Executive Officer, Director | 2026-09-02, 2023-02-21 |
| Joel Schoppig | Director | 2026-09-02 |
| Vishal Gulati | Director | 2026-09-02 |
Names and roles exactly as the filings list them: executive officers, directors and promoters. Nothing here is inferred, and a filing only lists the people it is required to.
On the SEC's company record
- Sensible Biotechnologies, Inc. is incorporated in Delaware, according to its company record with the SEC (CIK 1964363).
- The SEC record lists Sensible Biotechnologies, Inc.'s business address in Puchov, Slovakia, as of its latest filing on 2026-09-02.
- Sensible Biotechnologies, Inc. has 2 filings under its CIK, the first on 2023-02-21: 2 Form D (exempt offering notice) filings (full list).
Read from the company's own record with the SEC on 2026-09-28. Each line links to the record or filing it states.